Zalcman G, et al.; French Cooperative Thoracic Intergroup (IFCT). Bevacizumab for Newly Diagnosed Pleural Mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): A Randomised, Controlled, Open-Label, Phase 3 Trial. Lancet (16)-MedSci.cn

Zalcman G, et al.; French Cooperative Thoracic Intergroup (IFCT). Bevacizumab for Newly Diagnosed Pleural Mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): A Randomised, Controlled, Open-Label, Phase 3 Trial. Lancet (16)

Psallidas, I

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017; 196 (3): 384

科室
- - 订阅+
  - 更多科室
工具
服务